Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain
出版年份 2022 全文链接
标题
Selective inhibitors of SARM1 targeting an allosteric cysteine in the autoregulatory ARM domain
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 35, Pages -
出版商
Proceedings of the National Academy of Sciences
发表日期
2022-08-23
DOI
10.1073/pnas.2208457119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Constitutively active SARM1 variants that induce neuropathy are enriched in ALS patients
- (2022) A. Joseph Bloom et al. Molecular Neurodegeneration
- Structural basis of SARM1 activation, substrate recognition, and inhibition by small molecules
- (2022) Yun Shi et al. MOLECULAR CELL
- Reimagining high-throughput profiling of reactive cysteines for cell-based screening of large electrophile libraries
- (2021) Miljan Kuljanin et al. NATURE BIOTECHNOLOGY
- Small Molecule SARM1 Inhibitors Recapitulate the SARM1−/− Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
- (2021) Robert O. Hughes et al. Cell Reports
- SARM1 is a metabolic sensor activated by an increased NMN/NAD+ ratio to trigger axon degeneration
- (2021) Matthew D. Figley et al. NEURON
- Reimagining Druggability Using Chemoproteomic Platforms
- (2021) Jessica N. Spradlin et al. ACCOUNTS OF CHEMICAL RESEARCH
- Pharmacological SARM1 inhibition protects axon structure and function in paclitaxel-induced peripheral neuropathy
- (2021) Todd Bosanac et al. BRAIN
- One Atom Makes All the Difference: Getting a Foot in the Door between SOS1 and KRAS
- (2021) Juergen Ramharter et al. JOURNAL OF MEDICINAL CHEMISTRY
- Permeant fluorescent probes visualize the activation of SARM1 and uncover an anti-neurodegenerative drug candidate
- (2021) Wan Hua Li et al. eLife
- ATP-competitive partial antagonists of the IRE1α RNase segregate outputs of the UPR
- (2021) Hannah C. Feldman et al. Nature Chemical Biology
- Sarm1 activation produces cADPR to increase intra-axonal Ca++ and promote axon degeneration in PIPN
- (2021) Yihang Li et al. JOURNAL OF CELL BIOLOGY
- Neurotoxins subvert the allosteric activation mechanism of SARM1 to induce neuronal loss
- (2021) Tong Wu et al. Cell Reports
- Enrichment of SARM1 alleles encoding variants with constitutively hyperactive NADase in patients with ALS and other motor nerve disorders
- (2021) Jonathan Gilley et al. eLife
- Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1
- (2021) Andrea Loreto et al. eLife
- Evaluation of the NAD+ biosynthetic pathway in ALS patients and effect of modulating NAD+ levels in hSOD1-linked ALS mouse models
- (2020) Benjamin A. Harlan et al. EXPERIMENTAL NEUROLOGY
- Programmed axon degeneration: from mouse to mechanism to medicine
- (2020) Michael P. Coleman et al. NATURE REVIEWS NEUROSCIENCE
- An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
- (2020) Ekaterina V. Vinogradova et al. CELL
- Structural and Mechanistic Regulation of the Pro-degenerative NAD Hydrolase SARM1
- (2020) Matthew Bratkowski et al. Cell Reports
- Identification of the first noncompetitive SARM1 inhibitors
- (2020) Heather S. Loring et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The NAD+-mediated self-inhibition mechanism of pro-neurodegenerative Sarm1
- (2020) Yuefeng Jiang et al. NATURE
- Activation of the IRE1 RNase through remodeling of the kinase front pocket by ATP-competitive ligands
- (2020) Elena Ferri et al. Nature Communications
- A chemoproteomic portrait of the oncometabolite fumarate
- (2019) Rhushikesh A. Kulkarni et al. Nature Chemical Biology
- Covalent Ligand Screening Uncovers a RNF4 E3 Ligase Recruiter for Targeted Protein Degradation Applications
- (2019) Carl C. Ward et al. ACS Chemical Biology
- Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence
- (2019) Marshall Lukacs et al. EXPERIMENTAL NEUROLOGY
- Homozygous NMNAT2 mutation in sisters with polyneuropathy and erythromelalgia
- (2019) Peter Huppke et al. EXPERIMENTAL NEUROLOGY
- Reactive-cysteine profiling for drug discovery
- (2019) Aaron J Maurais et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Sarm1 deletion suppresses TDP-43-linked motor neuron degeneration and cortical spine loss
- (2019) Matthew A. White et al. Acta Neuropathologica Communications
- TIR Domain Proteins Are an Ancient Family of NAD + -Consuming Enzymes
- (2018) Kow Essuman et al. CURRENT BIOLOGY
- Systematic analysis of protein turnover in primary cells
- (2018) Toby Mathieson et al. Nature Communications
- Low levels of NMNAT2 compromise axon development and survival
- (2018) Jonathan Gilley et al. HUMAN MOLECULAR GENETICS
- Deletion of Sarm1 gene is neuroprotective in two models of peripheral neuropathy
- (2017) Elliot Turkiew et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- The SARM1 Toll/Interleukin-1 Receptor Domain Possesses Intrinsic NAD + Cleavage Activity that Promotes Pathological Axonal Degeneration
- (2017) Kow Essuman et al. NEURON
- Screening with an NMNAT2-MSD platform identifies small molecules that modulate NMNAT2 levels in cortical neurons
- (2017) Yousuf O. Ali et al. Scientific Reports
- Sarm1 Deletion, but Not Wld S , Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
- (2017) Jonathan Gilley et al. Cell Reports
- Designing small molecules to target cryptic pockets yields both positive and negative allosteric modulators
- (2017) Kathryn M. Hart et al. PLoS One
- Prevention of vincristine-induced peripheral neuropathy by genetic deletion of SARM1 in mice
- (2016) Stefanie Geisler et al. BRAIN
- Attenuated traumatic axonal injury and improved functional outcome after traumatic brain injury in mice lackingSarm1
- (2016) Nils Henninger et al. BRAIN
- Proteome-wide covalent ligand discovery in native biological systems
- (2016) Keriann M. Backus et al. NATURE
- Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor
- (2016) Yinglong Miao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARM1 activation triggers axon degeneration locally via NAD+ destruction
- (2015) J. Gerdts et al. SCIENCE
- Absence of SARM1 Rescues Development and Survival of NMNAT2-Deficient Axons
- (2015) Jonathan Gilley et al. Cell Reports
- Wallerian Degeneration Is Executed by an NMN-SARM1-Dependent Late Ca 2+ Influx but Only Modestly Influenced by Mitochondria
- (2015) Andrea Loreto et al. Cell Reports
- Enzyme Inhibitor Discovery by Activity-Based Protein Profiling
- (2014) Micah J. Niphakis et al. Annual Review of Biochemistry
- A rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
- (2014) M Di Stefano et al. CELL DEATH AND DIFFERENTIATION
- Wallerian degeneration: an emerging axon death pathway linking injury and disease
- (2014) Laura Conforti et al. NATURE REVIEWS NEUROSCIENCE
- A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles
- (2013) Chu Wang et al. NATURE METHODS
- Axon degeneration: Molecular mechanisms of a self-destruction pathway
- (2012) Jack T. Wang et al. JOURNAL OF CELL BIOLOGY
- dSarm/Sarm1 Is Required for Activation of an Injury-Induced Axon Death Pathway
- (2012) J. M. Osterloh et al. SCIENCE
- Quantitative reactivity profiling predicts functional cysteines in proteomes
- (2010) Eranthie Weerapana et al. NATURE
- Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy Axons
- (2010) Jonathan Gilley et al. PLOS BIOLOGY
- Nicotinamide Mononucleotide Adenylyl Transferase-Mediated Axonal Protection Requires Enzymatic Activity But Not Increased Levels of Neuronal Nicotinamide Adenine Dinucleotide
- (2009) Y. Sasaki et al. JOURNAL OF NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started